[HTML][HTML] Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
Background Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.
MA Puhan, LM Bachmann, J Kleijnen, G Ter Riet… - BMC Medicine, 2009 - europepmc.org
Background Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
[PDF][PDF] Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
MA Puhan, LM Bachmann, J Kleijnen, G ter Riet… - BMC …, 2009 - cyberleninka.org
Background: Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
[PDF][PDF] Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
MA Puhan, LM Bachmann, J Kleijnen, G ter Riet… - BMC …, 2009 - researchgate.net
Background: Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
MA Puhan, LM Bachmann… - BMC …, 2009 - researchinformation.amsterdamumc …
BACKGROUND: Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
MA Puhan, LM Bachmann, J Kleijnen, G ter Riet… - BMC Medicine, 2009 - zora.uzh.ch
BACKGROUND: Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
[PDF][PDF] Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
MA Puhan, LM Bachmann, J Kleijnen, G ter Riet… - BMC …, 2009 - scienceopen.com
Background: Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
MA Puhan, LM Bachmann, J Kleijnen… - BMC …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
[PDF][PDF] Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
MA Puhan, LM Bachmann, J Kleijnen, G ter Riet… - BMC Medicine, 2009 - dare.uva.nl
Background: Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …